Skip to main content
. 2020 Dec 1;71(Suppl 3):S276–S284. doi: 10.1093/cid/ciaa1323

Table 3.

Complications Between Drug Resistant and Sensitive Cases of S. Typhi in Karachi, Pakistan, September 2016–September 2019

S. Typhi (MDR/XDR Cases) S. Typhi (non MDR/ XDR Cases)
Complications n = 1650 % n = 443 % Pvalue
Hepatitis 20 1.2 1 .2 .1
Hemodynamic shock 13 .8 0 0 .083
Pulmonary complications 10 .6 0 0 .13
GI complication 9 .6 0 0 .22
Intestinal perforation 8 .5 0 0 .22
Sepsis 6 .4 0 0 .35
Intestinal obstruction 6 .4 1 .2 1
Encephalopathy 3 .2 2 .5 .29
Renal impairment 2 .1 0 0 1
Blood cell disorders 2 .1 0 0 1
Others (myocarditis/wound infection/disseminated intravascular coagulation (DIC) /musculoskeletal complications/electrolyte imbalance) 4 .2 0 0 .58
At least one or more than one complications iIndividuals) 58 3.5 4 .90 .005
All Admissionsa n = 710
mean (SD)
n = 145
mean (SD)
Duration/Days of hospitalization 9.98 (7.87) 10.43 (10.61) .555
Temperature at admissionb 101.45 (1.63) 101.18 (1.89) .109

aAll admissions includes patients recruited at OPD, IPD, Hospital Lab, Surgical.

bTemperature at admission: S. Typhi (MDR/XDR Cases) n = 687/710, information not available n = 23. S. Typhi (non MDR/ XDR Cases) n = 144/145, information not available n = 1.

S. Typhi = 831/855, information not available n = 24.